🟢 enGene Holdings is trading 7.6% up in pre-market; no clear catalyst identified

enGene Holdings is trading at $1.56, up 7.59% in pre-market, with no clear catalyst established.

• No company-specific announcement dated November 3 was found. The latest listed releases were an October 13 webinar announcement and September 8 quarterly results; neither establishes a fresh catalyst.
• Supplied market indicators are mixed, with no clear broad-market or sector explanation established. Trading volume and activity level are unavailable.